Psychiatry

Leigh Beglinger, PhD

Portrait

Associate Professor of Psychiatry

Contact Information

Office: 1-321 Medical Education Building
Iowa City, IA 52242
Office Phone: 319-335-8765

Email: leigh-beglinger@uiowa.edu

Education

BS, Psychology, University of Idaho, Moscow, ID
MS, Clinical Psychology, University of Idaho, Moscow, ID
PhD, Clinical Psychology, Washington State University, Pullman, WA

Post Doctorate, Clinical Neuropsychology, Indiana University, Indianapolis, IN

Licensure and Certifications

Health Service Provider in Psychology Iowa Bureau of Professional Licensing
Psychologist Iowa Bureau of Professional Licensing

Selected Publications

Show All

Beglinger L, Adams W, Langbehn D, Fiedorowicz J, Caviness J, Biglan K, Olson B, Paulsen J.  Does interval between screening and baseline matter in HD cognitive clinical trials? .  J Huntingtons Dis.  2014. 3(2):139-44.
[PubMed]

Yager J, Gasparovic C, Magnotta V, Adams W, Fiedorowicz J, Paulsen J, Jorge R, Beglinger L.  Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington's disease.  J Neuropsychiatry Clin Neurosci.  2014. 26(1):101-4.
[PubMed]

Beglinger L, Adams W, Langbehn D, Fiedorowicz J, Jorge R, Biglan K, Caviness J, Olson B, Robinson R, Kieburtz K, Paulsen J.  Results of the citalopram to enhance cognition in Huntington disease trial.  Mov Disord.  2014. 29(3):401-5.
[PubMed]

Epping E, Mills J, Beglinger L, Fiedorowicz J, Craufurd D, Smith M, Groves M, Bijanki K, Downing N, Williams J, Long J, Paulsen J.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.  J Psychiatr Res.  2013. 47(10):1423-31.
[PubMed]

Nguyen C, Yamada T, Beglinger L, Cavanaugh J, Denburg N, Schultz S.  Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions.  Psychooncology.  2013. 22(4):862-8.
[PubMed]

Nguyen C, Yamada T, Beglinger L, Cavanaugh J, Denburg N, Schultz S.  Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions.  Psychooncology.  2013. 22(4):862-8.
[PubMed]

Sieck B, Smith M, Paulsen J, Beglinger L.  Symptom validity test performance in the Huntington Disease Clinic.  Arch Clin Neuropsychol.  2013. 28(2):135-43.
[PubMed]

Rowe K, Paulsen J, Langbehn D, Wang C, Mills J, Beglinger L, Smith M, Epping E, Fiedorowicz J, Duff K, Ruggle A, Moser D.  Patterns of serotonergic antidepressant usage in prodromal Huntington disease.  Psychiatry Res.  2012. 196(2-3):309-14.
[PubMed]

Downing N, Smith M, Beglinger L, Mills J, Duff K, Rowe K, Epping E, Paulsen J.  Perceived stress in prodromal Huntington disease.  Psychol Health.  2012. 27(2):196-209.
[PubMed]

Weckmann M, Gingrich R, Mills J, Hook L, Beglinger L.  Risk Factors for Delirium in Patients Undergoing Hematopoietic Stem Cell Transplantation.  Ann Clin Psychiatry.  2012. 24(3):204-14.
[PubMed]

Date Last Modified: 06/07/2014 - 21:56:23